Company / Financials
Globus Medical Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$2.9B
FY2025 · +16.7% YoY
Net Income
$537.9M
FY2025 · +422.3% YoY
Profit Margin
18.3%
FY2025 · net income / revenue
ROE
11.8%
FY2025 · return on equity
Total Assets
$5.3B
FY2025
Total Debt
-
FY2025
Equity
$4.6B
FY2025
ROA
10.1%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- Altman Z-Score 3.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$2.9B+16.7% YoYNet Income HistoryProfit after all expenses and taxes$537.9M+422.3% YoYGross Profit HistoryRevenue minus cost of goods sold$1.0BCost of Revenue HistoryDirect costs of producing goods and services sold$957.8M-7.5% YoYOperating Income HistoryProfit from core business operations before interest and taxes$479.8M+189.1% YoYSG&A Expense HistorySelling, general, and administrative expenses$1.2B+20.1% YoYR&D Expense HistoryResearch and development spending$147.2M-10.1% YoYInterest Expense HistoryCost of borrowing and debt obligations$17.4MIncome Tax HistoryTotal income tax expense$67.2M+278.8% YoYEPS (Basic) HistoryBasic earnings per share$1.09-42.3% YoY